
| If you would like to search the entire site, then use the search box below | |
| SEARCH | |
| CONTACT |
enquiries@mspl.co.uk (+44) 0161 226 1000 |
Specialty contract research organisation, Euprotec Ltd, has moved into purpose built offices and laboratory space at Manchester Science Park’s Corridor site after strong business growth required a graduation from current premises at UMIC.

Euprotec works with biotech and large pharmaceutical companies across the world to accelerate the discovery and development of new and improved medicines to treat life-threatening infections and respiratory diseases, including those caused by multi-drug resistant bacteria and so-called ‘superbugs’.
Dr Lloyd Payne, CEO at Euprotec, said of the decision to relocate to Manchester Science Park: “We have always aspired to move to larger, purpose built facilities and msp provided an excellent opportunity for us to do so. For a fast growing business such as ours, it is an important natural progression to ‘graduate’ from the incubator at UMIC and move to our own dedicated space with potential for further expansion.
“Euprotec is in an exciting phase of growth and our success means we are in a position where, having benefitted from the support of the incubator facility, we have become less reliant on its services. We believe that our clients will benefit greatly from our relocation due to the additional important services we now offer as well as continued access to the university and biomedical networks that msp provides.”
Euprotec was established in 2008 and is experiencing strong growth with an increasing global presence. Since incorporation, it has established itself as an industry-leading organisation due to the high level of expertise within the company, as well as the extensive and innovative portfolio of services it offers. Underpinning its range of services is Euprotec’s vast collection of medically important bacteria and fungi which is used to determine how a new drug works and its potential for the treatment of emerging multi-drug resistant infections.
Lynne Barlow, Commercial Director at msp added: “Euprotec was borne out of experience and internationally recognised expertise in its field and we are especially pleased to have them as a tenant. We are confident that the business support services and contacts msp provides will be of value to the company as it continues to grow.”
Euprotec now occupies space on msp’s Corridor site, on a multi-year lease.
www.euprotec.com
Ends.